Application Note: Efficient Gene Editing of iPSCs
CellFE releases a cGMP-compatible workflow to support highly efficient gene editing of iPSCs via a non-viral approach for cell therapy manufacturing.
News
Categories
CellFE Announces Launch of First-in-Class T-Rest (“Resting T Cell Kit”) for Breakthrough CAR-T Cell Therapy Manufacturing
CellFE® today announced the launch of its highly anticipated CellFE T-Rest™, a first-in-class cell manufacturing transfection media product designed specifically for resting T cell workflows, along with an app note.
Application Note: CellFE CAR T Cell Editing
In the rapidly evolving field of cellular engineering, achieving complex gene edits with high efficiency and minimal workflow disruption remains a significant challenge.